These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 31408442)

  • 1. cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.
    Wang Z; Chen J; Hu J; Zhang H; Xu F; He W; Wang X; Li M; Lu W; Zeng G; Zhou P; Huang P; Chen S; Li W; Xia LP; Xia X
    J Clin Invest; 2019 Aug; 129(11):4850-4862. PubMed ID: 31408442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
    Hu M; Zhou M; Bao X; Pan D; Jiao M; Liu X; Li F; Li CY
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raddeanin A Enhances Mitochondrial DNA-cGAS/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43.
    Yin M; Dong J; Sun C; Liu X; Liu Z; Liu L; Kuang Z; Zhang N; Xiao D; Zhou X; Deng H
    Adv Sci (Weinh); 2023 May; 10(13):e2206737. PubMed ID: 36876644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
    Hossain DMS; Javaid S; Cai M; Zhang C; Sawant A; Hinton M; Sathe M; Grein J; Blumenschein W; Pinheiro EM; Chackerian A
    J Clin Invest; 2018 Feb; 128(2):644-654. PubMed ID: 29337311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
    Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
    J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.
    Mender I; Zhang A; Ren Z; Han C; Deng Y; Siteni S; Li H; Zhu J; Vemula A; Shay JW; Fu YX
    Cancer Cell; 2020 Sep; 38(3):400-411.e6. PubMed ID: 32619407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
    Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
    Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling.
    Zhang H; Tang K; Zhang Y; Ma R; Ma J; Li Y; Luo S; Liang X; Ji T; Gu Z; Lu J; He W; Cao X; Wan Y; Huang B
    Cancer Immunol Res; 2015 Feb; 3(2):196-205. PubMed ID: 25477253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREX1 as a Novel Immunotherapeutic Target.
    Hemphill WO; Simpson SR; Liu M; Salsbury FR; Hollis T; Grayson JM; Perrino FW
    Front Immunol; 2021; 12():660184. PubMed ID: 33868310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms.
    Wang Y; Mohseni M; Grauel A; Diez JE; Guan W; Liang S; Choi JE; Pu M; Chen D; Laszewski T; Schwartz S; Gu J; Mansur L; Burks T; Brodeur L; Velazquez R; Kovats S; Pant B; Buruzula G; Deng E; Chen JT; Sari-Sarraf F; Dornelas C; Varadarajan M; Yu H; Liu C; Lim J; Hao HX; Jiang X; Malamas A; LaMarche MJ; Geyer FC; McLaughlin M; Costa C; Wagner J; Ruddy D; Jayaraman P; Kirkpatrick ND; Zhang P; Iartchouk O; Aardalen K; Cremasco V; Dranoff G; Engelman JA; Silver S; Wang H; Hastings WD; Goldoni S
    Sci Rep; 2021 Jan; 11(1):1399. PubMed ID: 33446805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
    Xu H; Van der Jeught K; Zhou Z; Zhang L; Yu T; Sun Y; Li Y; Wan C; So KM; Liu D; Frieden M; Fang Y; Mosley AL; He X; Zhang X; Sandusky GE; Liu Y; Meroueh SO; Zhang C; Wijeratne AB; Huang C; Ji G; Lu X
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit.
    Wang J; Fei K; Jing H; Wu Z; Wu W; Zhou S; Ni H; Chen B; Xiong Y; Liu Y; Peng B; Yu D; Jiang H; Liu J
    MAbs; 2019; 11(8):1443-1451. PubMed ID: 31402780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MUS81 promotes the anticancer effect of WEE1 inhibitor and immune checkpoint blocking combination therapy via activating cGAS/STING signaling in gastric cancer cells.
    Li C; Shen Q; Zhang P; Wang T; Liu W; Li R; Ma X; Zeng X; Yin Y; Tao K
    J Exp Clin Cancer Res; 2021 Oct; 40(1):315. PubMed ID: 34625086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway.
    Zhang Y; Zhao H; Deng W; Lai J; Sang K; Chen Q
    Commun Biol; 2024 May; 7(1):587. PubMed ID: 38755254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
    Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
    Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation.
    Gulla A; Morelli E; Samur MK; Botta C; Hideshima T; Bianchi G; Fulciniti M; Malvestiti S; Prabhala RH; Talluri S; Wen K; Tai YT; Richardson PG; Chauhan D; Sewastianik T; Carrasco RD; Munshi NC; Anderson KC
    Blood Cancer Discov; 2021 Sep; 2(5):468-483. PubMed ID: 34568832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.